Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.71
Delayed Data
As of 2:14pm ET
 -0.0059 / -0.22%
Today’s Change
1.93
Today|||52-Week Range
5.70
-14.46%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.72
Today’s open2.71
Day’s range2.64 - 2.77
Volume5,985
Average volume (3 months)14,869
Market cap$14.0M
Dividend yield--
Data as of 2:14pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.78

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc+0.04+11.81%
CYANCyanotech Corp-0.05-1.03%
IBIOIbio Inc-0.02-4.87%
ISRIsoRay Inc-0.01-1.79%
Data as of 3:33pm ET, 08/17/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts